ERBB2 and breast cancer: They found that AUC, SE, and SP of the model distinguished between breast cancer of HR-positivity with HER2-negativity and TNBC were 0.760 (95%CI: 0.755, 0.764), 97.9%, and 60.1%, respectively (27).